Latest News

 Filter by Provider

Treasury Secretary Scott Bessent on Wednesday urged the central bank to be more open in its policymaking approach going forward.

CEO Carlos Abrams-Rivera said the company delivered growth in the international away-from-home channel while the overall U.S. away-from-home industry continues to face pressure due to traffic headwinds.

A Paradise Acquisition floated the initial public offering with 20 million units on offer, at an offer price of $10.

This marks the company’s first footstep in Latin America, and of the 20 screens, 18 will be built in the U.S.

Alicia Boler Davis’s appointment will be effective Oct. 1, and she will succeed Andrew Frick, who has served as interim leader of the segment since last year.

After opening the day higher, the benchmark indices continued their upward momentum, ended the session in green.

LendingClub reported fantastic second-quarter earnings results.

NVO stock is now down 65% from last year's high.

Investors anticipate Trumpflation as President Trump's inflation-stoking policies, including tariffs and deficit spending, may drive up costs and impact markets.

The upcoming financial update could create significant volatility in the aftermath.

Give the answer as a plain text string, without double quotes:Amazon will pay NYT $20-25M annually for licensing deal, shows value of journalism in AI era. Similar pacts by OpenAI, Google, and Reddit.

The management team revealed insights on several business segments.

Tesla is facing challenges, including distractions, competition, and a drop in demand. Musk plans to reboot with a trio of high-risk bets and a $16.5B chip deal, dividing opinions among investors.

Garmin's Q2 2025 results reveal strong performance, with significant growth across all segments, surpassing market expectations.

UnitedHealth Group remained volatile in early trading, after the company Tuesday reported downbeat second-quarter results.

Trane Technologies (NYSE: TT) raised guidance after strong Q2 earnings and record bookings. Americas Commercial HVAC segment drove growth, shares fell 8%.

The data protection and cybersecurity company received price target boosts from several brokerages, citing strong performance and momentum in the backup and recovery segment.

Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.

The reversal of the frontloading effect on exports played a key role here, and domestic demand was clearly too weak to compensate